CARDIFF ONCOLOGY, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
CARDIFF ONCOLOGY, INC. (CRDF) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $920.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-11
- CARDIFF ONCOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $920.00K, a 45.34% decline year-over-year.
- CARDIFF ONCOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $1.66M, a 21.61% increase year-over-year.
- CARDIFF ONCOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $1.38M, a 10.45% increase year-over-year.
- CARDIFF ONCOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $1.68M, a 42.75% increase year-over-year.
- CARDIFF ONCOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $5.69M, a 19.60% increase from fiscal 2024.
- CARDIFF ONCOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $4.76M, a 5.57% increase from fiscal 2023.
- CARDIFF ONCOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $4.51M, a 5.94% increase from fiscal 2022.
- CARDIFF ONCOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $4.26M, a 31.60% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 11 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $920.00K 10-Q · filed 2026-08-11 | $2.58M derived: sum of 2 quarters · filed 2026-08-11 | |||||
| 2026-03-31 | $1.66M 10-Q · filed 2026-08-11 | ||||||
| 2025-12-31 | $5.69M 10-K · filed 2026-02-24 | ||||||
| 2025-09-30 | $1.38M 10-Q · filed 2025-11-06 | $3.07M derived: sum of 2 quarters · filed 2026-08-11 | $4.43M derived: sum of 3 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $1.68M 10-Q · filed 2026-08-11 | $3.05M derived: sum of 2 quarters · filed 2026-08-11 | |||||
| 2025-03-31 | $1.36M 10-Q · filed 2026-08-11 | ||||||
| 2024-12-31 | $4.76M 10-K · filed 2026-02-24 | ||||||
| 2024-09-30 | $1.25M 10-Q · filed 2025-11-06 | $2.43M derived: sum of 2 quarters · filed 2025-11-06 | $3.56M derived: sum of 3 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $1.18M 10-Q · filed 2025-11-06 | $2.30M derived: sum of 2 quarters · filed 2025-11-06 | |||||
| 2024-03-31 | $1.12M 10-Q · filed 2025-11-06 | ||||||
| 2023-12-31 | $4.51M 10-K · filed 2025-02-27 | ||||||
| 2023-09-30 | $955.00K 10-Q · filed 2024-11-07 | $2.54M derived: sum of 2 quarters · filed 2024-11-07 | $3.60M derived: sum of 3 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $1.58M 10-Q · filed 2024-11-07 | $2.65M derived: sum of 2 quarters · filed 2024-11-07 | |||||
| 2023-03-31 | $1.06M 10-Q · filed 2024-11-07 | ||||||
| 2022-12-31 | $4.26M 10-K · filed 2024-02-29 | ||||||
| 2022-09-30 | $1.04M 10-Q · filed 2023-11-02 | $2.09M derived: sum of 2 quarters · filed 2023-11-02 | $3.24M derived: sum of 3 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | $1.05M 10-Q · filed 2023-11-02 | $2.21M derived: sum of 2 quarters · filed 2023-11-02 | |||||
| 2022-03-31 | $1.15M 10-Q · filed 2023-11-02 | ||||||
| 2021-12-31 | $3.23M 10-K · filed 2023-03-02 | ||||||
| 2021-09-30 | $940.00K 10-Q · filed 2022-11-03 | $1.98M derived: sum of 2 quarters · filed 2022-11-03 | $2.24M derived: sum of 3 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $1.04M 10-Q · filed 2022-11-03 | $1.30M derived: sum of 2 quarters · filed 2022-11-03 | |||||
| 2021-03-31 | $268.00K 10-Q · filed 2022-11-03 | ||||||
| 2020-12-31 | $1.76M 10-K · filed 2022-02-24 | $1.76M 10-K · filed 2021-02-25 | |||||
| 2020-09-30 | $362.00K 10-Q · filed 2021-11-04 | $361.88K 10-Q · filed 2020-11-05 | $644.00K derived: sum of 2 quarters · filed 2021-11-04 | $821.00K derived: sum of 3 quarters · filed 2021-11-04 | |||
| 2020-06-30 | $282.00K 10-Q · filed 2021-11-04 | $281.78K 10-Q · filed 2020-08-11 | $459.00K derived: sum of 2 quarters · filed 2021-11-04 | ||||
| 2020-03-31 | $177.00K 10-Q · filed 2021-11-04 | $177.31K 10-Q · filed 2020-05-07 | |||||
| 2019-12-31 | $884.94K 10-K · filed 2021-02-25 | ||||||
| 2019-09-30 | $266.32K 10-Q · filed 2020-11-05 | $415.16K derived: sum of 2 quarters · filed 2020-11-05 | $615.23K derived: sum of 3 quarters · filed 2020-11-05 | $884.20K derived: sum of 4 quarters · filed 2020-11-05 | |||
| 2019-06-30 | $148.83K 10-Q · filed 2020-11-05 | $348.90K derived: sum of 2 quarters · filed 2020-11-05 | $617.88K derived: sum of 3 quarters · filed 2020-11-05 | $896.10K derived: sum of 4 quarters · filed 2020-11-05 | |||
| 2019-03-31 | $200.07K 10-Q · filed 2020-11-05 | $469.04K derived: sum of 2 quarters · filed 2020-11-05 | $747.26K derived: sum of 3 quarters · filed 2020-11-05 | $968.56K derived: sum of 4 quarters · filed 2020-11-05 | |||
| 2018-12-31 | $268.98K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $547.20K derived: sum of 2 quarters · filed 2020-02-27 | $768.50K derived: sum of 3 quarters · filed 2020-02-27 | $2.17M 10-K · filed 2020-02-27 | |||
| 2018-09-30 | $278.22K 10-Q · filed 2019-11-07 | $499.52K derived: sum of 2 quarters · filed 2019-11-07 | $1.91M 10-Q · filed 2018-11-07 | ||||
| 2018-06-30 | $221.30K 10-Q · filed 2019-11-07 | $1.63M 10-Q · filed 2018-08-03 | |||||
| 2018-03-31 | $1.41M 10-Q · filed 2019-11-07 | ||||||
| 2017-12-31 | $4.01M 10-K · filed 2019-03-06 | ||||||
| 2016-12-31 | $7.50M 10-K · filed 2018-02-26 | ||||||
| 2015-12-31 | $3.95M 10-K · filed 2017-03-15 | ||||||
| 2014-12-31 | $2.07M 10-K · filed 2017-03-15 | ||||||
| 2013-12-31 | $321.47K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $1.44M derived: sum of 2 quarters · filed 2016-03-10 | $1.76M derived: sum of 3 quarters · filed 2016-03-10 | $1.98M 10-K · filed 2016-03-10 | |||
| 2013-09-30 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $1.44M derived: sum of 2 quarters · filed 2013-11-14 | $1.66M 10-Q · filed 2013-11-14 | $1.84M derived: sum of 4 quarters · filed 2015-03-12 | |||
| 2013-06-30 | $323.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $541.45K 10-Q · filed 2013-08-14 | $724.58K derived: sum of 3 quarters · filed 2015-03-12 | $854.94K derived: sum of 4 quarters · filed 2015-03-12 | |||
| 2013-03-31 | $217.92K 10-Q · filed 2013-05-14 | $401.05K derived: sum of 2 quarters · filed 2015-03-12 | $531.41K derived: sum of 3 quarters · filed 2015-03-12 | $647.23K derived: sum of 4 quarters · filed 2015-03-12 | |||
| 2012-12-31 | $183.13K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $313.49K derived: sum of 2 quarters · filed 2015-03-12 | $429.31K derived: sum of 3 quarters · filed 2015-03-12 | $532.14K 10-K · filed 2015-03-12 | |||
| 2012-09-30 | $130.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $246.18K derived: sum of 2 quarters · filed 2012-11-14 | $349.01K 10-Q · filed 2012-11-14 | ||||
| 2012-06-30 | $115.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $218.65K 10-Q · filed 2012-08-14 | |||||
| 2012-03-31 | $102.83K 10-Q · filed 2012-05-15 | ||||||
| 2011-12-31 | $250.98K 10-K · filed 2014-03-17 | ||||||
| 2010-12-31 | $325.93K 10-K · filed 2014-03-17 | ||||||
| 2009-12-31 | $177.84K 10-K · filed 2014-03-17 | ||||||
| 2008-12-31 | $543.70K 10-K · filed 2014-03-17 | ||||||
| 2007-12-31 | $914.85K 10-K · filed 2014-03-17 | ||||||
| 2007-01-31 | $1.57M 10-K · filed 2014-03-17 | ||||||
| 2006-01-31 | $2.93M 10-K · filed 2014-03-17 | ||||||
| 2005-01-31 | $0.00 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |